Interpace Biosciences, Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $2.7M | $2.6M | $2.5M | $1.4M | $502.0K | $1.2M | $1.5M | $1.4M |
| Accounts Receivable | $6.3M | $5.9M | $5.6M | $6.0M | $7.2M | $8.8M | $8.5M | $7.3M |
| Inventory | $1.1M | $961.0K | $1.1M | $1.1M | $973.0K | $1.2M | $1.2M | $1.2M |
| Total Current Assets | $11.0M | $10.0M | $9.9M | $9.1M | $9.5M | $11.7M | $11.8M | $9.1M |
| Property, Plant & Equipment | $1.6M | $1.3M | $1.4M | $1.5M | $1.4M | $1.3M | $1.4M | $1.4M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $34.5M | $33.4M | $33.8M | $12.0M | $12.3M | $14.5M | $14.8M | $14.0M |
| Liabilities | ||||||||
| Accounts Payable | $1.6M | $805.0K | $983.0K | $1.4M | $1.3M | $1.7M | $1.7M | $1.7M |
| Total Current Liabilities | $5.0M | $4.0M | $5.1M | $5.9M | $7.1M | $8.7M | $10.6M | $5.9M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $11.3M | $10.3M | $11.5M | $12.3M | $13.5M | $15.1M | $17.0M | $18.0M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-209.9M | $-210.1M | $-210.8M | $-233.5M | $-234.4M | $-233.7M | $-235.4M | $-237.3M |
| Total Stockholders' Equity | $23.2M | $23.1M | $22.4M | $-298.0K | $-1.2M | $-582.0K | $-2.2M | $-50.5M |